CDK4 and neoplasm: By comparing the cfDNA WGS with sequencing on the primary tumor and metastasis at the time of relapse, we demonstrated a high degree of concordance in the identification of key genomic alterations, including MYCN and CDK4/MDM2 amplifications (Figure 2; Supplementary Figure S1B).